Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
Late onset Pneumocystis pneumonia in patients receiving rituximab for humoral renal transplant rejection
Nephrology, 10/07/09
Shelton E et al. – Rituximab has been used increasingly in the treatment of antibody–mediated rejection (AbMR) in solid organ transplantation despite the absence of clinical trials demonstrating efficacy. These cases emphasize the need for ongoing vigilant observation in patients who have received rituximab, and highlight the importance of clinical trials to establish the role of rituximab in prevention and treatment of AbMR.
Related Articles
Is short term outcome of Iranian renal transplant recipients affected by mean first 6 months C2 level
Saudi Journal of Kidney Diseases and Transplantation, 11/10/09
Relevance Score: 70%
Value of serum cystatin C as a marker of renal function in the early post kidney transplant period
Saudi Journal of Kidney Diseases and Transplantation, 11/02/09
Relevance Score: 70%
Multidisciplinary treatment including sorafenib stabilized the bone metastases of renal cell carcinoma in an immunosuppressed renal transplant recipient
International Journal of Clinical Oncology, 10/30/09
Relevance Score: 70%
Renal transplantation in a HIV positive patient
Indian Journal of Nephrology, 10/20/09
Relevance Score: 70%
Uric Acid Levels Have No Significant Effect on Renal Function in Adult Renal Transplant Recipients: Evidence from the Symphony Study
Clinical Journal of the American Society of Nephrology, 10/08/09
Relevance Score: 70%
Today in Transplantation...keeping you current
Receive free subspecialty "5-minute updates" via email
Prevalence and predictors of recurrent IgA nephropathy following renal transplantation
Irish Journal of Medical Science, 12/18/09
Renal Function Outcomes in Kidney Transplant Recipients After Conversion to Everolimus-Based Immunosuppression Regimen with CNI Reduction or Elimination
Transplantation Proceedings, 12/18/09
Late Acute Kidney Transplant Rejection: Clinicopathological Correlates and Response to Corticosteroid Therapy
Transplantation Proceedings, 12/18/09
Article Search
Sponsor


See Latest Articles


